Trial · NCT02958865
Adverse events928
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 928
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Placebo (Induction) | 1 | 25 | |
| other | Anaemia | Blood and lymphatic system disorders | PF-06651600 20 mg (Induction) | 1 | 51 | |
| other | Anaemia | Blood and lymphatic system disorders | PF-06651600 70 mg (Induction) | 2 | 49 | |
| other | Anaemia | Blood and lymphatic system disorders | PF-06651600 200 mg (Induction) | 4 | 50 | |
| other | Anaemia | Blood and lymphatic system disorders | PF-06700841 10 mg (Induction) | 1 | 48 | |
| other | Anaemia | Blood and lymphatic system disorders | PF-06700841 30 mg (Induction) | 1 | 47 | |
| other | Anaemia | Blood and lymphatic system disorders | PF-06700841 60 mg (Induction) | 4 | 47 | |
| other | Anaemia | Blood and lymphatic system disorders | PF-06651600 200 mg -> PF-06651600 50 mg | 1 | 35 | |
| other | Anaemia | Blood and lymphatic system disorders | PF-06651600 70 mg -> PF-06651600 50 mg | 0 | 36 | |
| other | Anaemia | Blood and lymphatic system disorders | PF-06651600 20 mg -> PF-06651600 50 mg | 0 | 39 | |
| other | Anaemia | Blood and lymphatic system disorders | Placebo -> PF-06651600 50 mg | 1 | 10 | |
| other | Anaemia | Blood and lymphatic system disorders | PF-06700841 60 mg -> PF-06700841 30 mg | 1 | 38 | |
| other | Anaemia | Blood and lymphatic system disorders | PF-06700841 30 mg -> PF-06700841 30 mg | 0 | 37 | |
| other | Anaemia | Blood and lymphatic system disorders | PF-06700841 10 mg -> PF-06700841 30 mg | 2 | 39 | |
| other | Anaemia | Blood and lymphatic system disorders | Placebo -> PF-06700841 30 mg | 1 | 9 | |
| other | Anaemia | Blood and lymphatic system disorders | Pooling Placebo During Chronic | 2 | 37 | |
| other | Abdominal pain | Gastrointestinal disorders | Placebo (Induction) | 2 | 25 | |
| other | Abdominal pain | Gastrointestinal disorders | PF-06651600 20 mg (Induction) | 1 | 51 | |
| other | Abdominal pain | Gastrointestinal disorders | PF-06651600 70 mg (Induction) | 1 | 49 | |
| other | Abdominal pain | Gastrointestinal disorders | PF-06651600 200 mg (Induction) | 0 | 50 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02958865/events